These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68. Topical application of antiangiogenic agent AGM-1470 suppresses anastomotic intimal hyperplasia after ePTFE grafting in a rabbit model. Shigematsu K; Yasuhara H; Shigematsu H Surgery; 2001 Feb; 129(2):220-30. PubMed ID: 11174715 [TBL] [Abstract][Full Text] [Related]
69. Remodeling and suppression of intimal hyperplasia of vascular grafts with a distal arteriovenous fistula in a rat model. Qin F; Dardik H; Pangilinan A; Robinson J; Chuy J; Wengerter K J Vasc Surg; 2001 Oct; 34(4):701-6. PubMed ID: 11668327 [TBL] [Abstract][Full Text] [Related]
70. Prevention of neointimal proliferation by immunosuppression in synthetic vascular grafts. Walpoth BH; Pavlicek M; Celik B; Nicolaus B; Schaffner T; Althaus U; Hess OM; Carrel T; Morris RE Eur J Cardiothorac Surg; 2001 Apr; 19(4):487-92. PubMed ID: 11306318 [TBL] [Abstract][Full Text] [Related]
71. Boundary layer infusion of heparin prevents thrombosis and reduces neointimal hyperplasia in venous polytetrafluoroethylene grafts without systemic anticoagulation. Chen C; Hanson SR; Lumsden AB J Vasc Surg; 1995 Sep; 22(3):237-45; discussion 246-7. PubMed ID: 7674466 [TBL] [Abstract][Full Text] [Related]
72. Growth factor production after polytetrafluoroethylene and vein arterial grafting: an experimental study. Sterpetti AV; Lepidi S; Cucino A; Patrizi AL; Palumbo R; Taranta A; Stipa F; Cavallaro A; Santoro-D'Angelo L; Stipa S J Vasc Surg; 1996 Mar; 23(3):452-60. PubMed ID: 8601887 [TBL] [Abstract][Full Text] [Related]
73. Isolation of genes differentially expressed at the downstream anastomosis of prosthetic arterial grafts with use of mRNA differential display. Hamdan AD; Aiello LP; Quist WC; Ozaki CK; Contreras MA; Phaneuf MD; Ruiz C; King GL; LoGerfo FW J Vasc Surg; 1995 Feb; 21(2):228-34. PubMed ID: 7853596 [TBL] [Abstract][Full Text] [Related]
74. [External ionizing radiation on the prosthesis-arterial anastomosis for the prevention of intimal hyperplasia and study of biomechanical resistance. Experiments and results]. Ducasse E; Cosset JM; Eschwege F; Mazurier J; Creusy C; Chevalier J; Puppinck P; Lartigau E Ann Chir; 2003 Nov; 128(9):603-9. PubMed ID: 14659614 [TBL] [Abstract][Full Text] [Related]
75. Vein to artery grafts: a morphological and histochemical study of the histogenesis of intimal hyperplasia. Dilley RJ; McGeachie JK; Tennant M Aust N Z J Surg; 1992 Apr; 62(4):297-303. PubMed ID: 1550522 [TBL] [Abstract][Full Text] [Related]
76. [New experimental rabbit model with PTFE grafts interpositioned in infrarenal abdominal aorta--influence of hyperlipidemia in prosthetic grafts]. Haruta N; Fukuda Y; Dohi K Jikken Dobutsu; 1991 Jan; 40(1):55-60. PubMed ID: 2007435 [TBL] [Abstract][Full Text] [Related]
77. Probucol reduces the cellularity of aortic intimal thickening at anastomotic regions adjacent to prosthetic grafts in cholesterol-fed rabbits. Baumann DS; Doblas M; Schonfeld G; Sicard GA; Daugherty A Arterioscler Thromb; 1994 Jan; 14(1):162-7. PubMed ID: 8274472 [TBL] [Abstract][Full Text] [Related]
78. Effects of rivaroxaban on intimal hyperplasia and smooth muscle cell proliferation at the carotid artery anastomosis site in rabbits. Akkaya G; Bilen Ç; Gençpınar T; Akokay P; Uğurlu B Anatol J Cardiol; 2017 Oct; 18(4):261-265. PubMed ID: 29076814 [TBL] [Abstract][Full Text] [Related]
79. Intimal hyperplasia of experimental autologous vein graft in hyperlipidemic rabbits with poor distal runoff. Itoh H; Komori K; Funahashi S; Okadome K; Sugimachi K Atherosclerosis; 1994 Oct; 110(2):259-70. PubMed ID: 7848374 [TBL] [Abstract][Full Text] [Related]
80. The early and late responses of the arterial wall to graft placement. Mason RA; Campbell R; Cassel W; Newton GB; Hui JC; Giron F J Surg Res; 1989 Nov; 47(5):383-8. PubMed ID: 2811354 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]